ClinicalTrials.gg
RecruitingNCT04921865Updated Aug 29, 2025

Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems

An observational study in Clavicle, Acromioclavicular Joint and Fracture, sponsored by AO Innovation Translation Center. Recruiting at 7 sites in 4 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-29.

Sponsored by AO Innovation Translation Center · Observational

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 4 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
76
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to gather early and mid- to long-term evidence to confirm the clinical performance, safety and use of the Clavicle Plate and Clavicle Hook Plate System.

A minimum of 76 patients with clavicle fractures or dislocations of the AC joint surgically treated with any plate from the DPS VA-LCP Clavicle System will be enrolled in this observational post-market clinical investigation.

Outcomes will be collected until up to 2 years after surgery.

Read the detailed description

Common problems with existing clavicular plates are poor plate 'fit,' unbalance fixation, plate prominence, associated soft tissue irritation, subacromial pain, plate and/or fixation failure (due to unbalanced fixation) and high reoperation rate (for plate removal) [1-3]. The newly developed DePuy Synthes (DPS) variable angle locking compression plate (VA-LCP®) Clavicle 2.7 System was designed to address these problems. The system consists of lateral, shaft and medial plates and hook plates of different sizes to cover a wide variation in clavicular morphology and diverse fracture, fracture-dislocation and dislocation indications.

The objective is to describe the short and long-term clinical performance and safety of both systems, as well as the functional outcomes of this patient population.

Outcomes will be collected at baseline, 2 weeks, 6 weeks, 3 months, 6 months 1, and 2 years after surgery. In addition, the surgeons' experience and utility of the devices will be surveyed. For the short term evaluation, an interim analysis will be done as soon as 30 patients in each group have completed 6 months of follow-up (FU). The final evaluation of long-term outcomes will be done after 2 years of FU.

All treatments and follow-up visits are according to standard of care.

02

Conditions studied

  • Clavicle
  • Acromioclavicular Joint
  • Fracture

Browse trials for

03

In context

Fractures, Bone

723 studies on the registry are indexed under Fractures, Bone; 114 are open to participants now.

This study's planned enrollment of 76 is below the median of 130 across 239 observational studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

AO Innovation Translation Center is the lead sponsor of 32 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Any patients treated with the DPS VA-LCP® Clavicle Plate 2.7 System or the DPS VA-LCP® Clavicle Hook Plate 2.7 System for clavicular fracture or dislocations of the acromioclavicular joint

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >= 18 years
  • Unilateral clavicel injury and primary surgical treatment within 21 days from injury with a DPS VA-LCP® Clavicle Plate according to manufacturer's instruction use:

    • VA-LCP® Clavicle Plates 2.7: Fixation of clavicle bone fragments
    • VA-LCP® Clavicle Hook Plates 2.7: Fixation of lateral clavicle fractures and dislocations of the acromioclavicular joint
    • VA-LCP Clavicle Button Hook Plates 2.7: Fixation of acromioclavicular joint dislocations
  • Expected ability to attend postoperative FU visits
  • Patient informed and consent obtained according to the IRB/EC defined and approved procedures

Exclusion criteria

Exclusion Criteria:

  • Stable clavicle fractures
  • Systemic infection or infection localized to the site of the proposed implantation
  • Concomitant nerve or vessel injury
  • Polytrauma (Injury Severity Score ≥ 16)
  • ≥40
  • Uncontrolled severe systemic disease or terminal illness
  • Intraoperative decision to use other implant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
76 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients treated with the DPS VA-LCP® Clavicle Plate 2.7 System or Hook Plate 2.7 System

    Any patient undergoing surgical treatment for the fixation of clavicle bone fragments and acromioclavicular joint dislocations using the DPS VA-LCP® Clavicle Plate 2.7 System or DPS VA-LCP® Clavicle Clavicle Hook Plate 2.7 .

    Device: DPS VA-LCP® Clavicle Plate 2.7 System; DPS VA-LCP® Clavicle Hook Plate 2.7 System

Interventions

  • DeviceDPS VA-LCP® Clavicle Plate 2.7 System; DPS VA-LCP® Clavicle Hook Plate 2.7 System

    The DPS VA-LCP® Clavicle Plate 2.7 System is indicated for the fixation of clavicle bone fragments. The system consists of three plate types: lateral, shaft, and medial, each available in different sizes and materials (titanium alloy and stainless steel). Each plate is available in left and right. The DPS VA-LCP® Clavicle Clavicle Hook Plate 2.7 System is indicated or the fixation of lateral clavicle fractures and AC joint dislocations. The Clavicle Hook Plate system consists of three plate types: long, short and button plates.

06

What researchers measure

Primary outcomes

  1. Safety aspects

    Adverse events (AE) related or possibly related to the investigational device (ADE) or the procedure

    Time frame: Patients treated with clavicle plate: From baseline up to 24 months after surgery; Patients treated with clavicle hook plate: From baseline until device removal (approximately 3months) and up to 12 months after device removal

  2. Clinical performance

    The outcome measures for clinical performance are a subcategory of safety-related parameters (e.g. incidence of complaints related to plate prominence or discomfort, fracture union rate, rate of stable AC joint healing)

    Time frame: Through study completion, an average of 1 year

  3. Utility in terms of surgeons' experience

    Surgeons satisfaction with the use and handling of the devices is evaluated in a questionnaire using 5-point Likert scale questions. These include: * Surgical time (skin to skin) required for fracture reduction and fixation * Much less time than with other implants * Slightly less time than with other implants * No difference with other implants * More time than with other implants * Much more time than with other implants * Surgeon's impression of the fitting of the device * Implant fitted well, no contouring required * Implant fitted well, minimal contouring required * Implant fitted well laterally but required contouring medially * Implant fitted well medially but required contouring laterally * Implant required contouring medially and laterally

    Time frame: Assessed immediately after the surgery

  4. Surgical time

    Surgical time in minutes

    Time frame: Assessed immediately after surgeries

  5. Fluoroscopy time

    Fluoroscopy time in minutes

    Time frame: Assessed immediately after surgeries

  6. The Disabilities of the Arm Shoulder and Hand short form (QuickDASH)

    The Disabilities of the Arm Shoulder and Hand short form (QuickDASH) questionnaire was designed as an occupational health and disability questionnaire. It includes 30 questions that have to be rated from 1 ("no difficulty") to 5 ("unable") where lower values indicate less disability and higher values indicate more disability.

    Time frame: Patients treated with clavicle plate: From baseline up to 24 months after surgery; Patients treated with clavicle hook plate: From baseline until device removal (approximately 3months) and up to 12 months after device removal

  7. Patient-Reported Outcomes Measurement Information System (PROMIS)

    The PROMIS Physical Function Upper Extremity Short Form 7a v2.0 (2018) consists of 7 questions aimed to evaluate activities that require use of the upper extremity including shoulder, arm, and hand activities. Questions can be rated from 1 "without any difficulties" to 5 "unable to do" where lower values indicate less disability and higher values indicate more disability.

    Time frame: Patients treated with clavicle plate: From baseline up to 24 months after device implantation surgery; Patients treated with clavicle hook plate: From baseline until device removal surgery (approximately 3months) and up to 12 months after device removal

Other outcomes

  1. Patient characteristics

    Demographics

    Time frame: Baseline

  2. Patient characteristics

    Height in centimeters

    Time frame: Baseline

  3. Patient characteristics

    Weight in kilograms

    Time frame: Baseline

  4. Patient characteristics

    Body Mass Index (BMI) in kg/m\^2

    Time frame: Baseline

  5. Comorbidities

    Concomitant diseases will be assessed using the Charlson Comorbidity Index (CCI). This score assesses the comorbidity level by considering both the number and severity of pre-defined comorbid conditions. It provides a weighted score of a patient's comorbidities which can be used to predict mortality risk. The minimum possible score is 0 (no comorbidities) and maximum 29. The higher the score, the more likely the predicted outcome will result in mortality.

    Time frame: Baseline

  6. Injury details

    Date of injury. Only the year of birth will be assessed.

    Time frame: Baseline

  7. Injury details

    Side injured (i.e. left/right)

    Time frame: Baseline

  8. Fracture classification

    \- Clavicle fracture will be recorded using two classifications: AO/OTA Classification and Robinson Classification \- AC joint dislocation: Rockwood classification

    Time frame: Baseline

  9. Surgical details

    Date of surgery

    Time frame: Intraoperative

  10. Surgical time

    Surgical time (i.e. defined as skin-to-skin time) in minutes

    Time frame: Intraoperative

  11. Plate details

    Clavicle Plate System * Type of plate and size * Lateral * CS1 * CS2 * CS3 * Shaft * CS1 * CS2 * CS3 * XL * Medial * Material * Stainless steel * Titanium alloy Clavicle Hook System * Type of plate and hook depth * Long * 9 mm * 12 mm * 15 mm * Short * 9 mm * 12 mm * 15 mm * Button * 9 mm * 12 mm * 15 mm * Material * Stainless steel * Titanium alloy

    Time frame: Intraoperative

  12. Screw details

    Screw details will be documented per fragment side (medial and lateral) as: * Number of screws * Diameter * Type * variable angle locking * metaphyseal * cortex

    Time frame: Intraoperative

  13. Adjunctive fixations

    * Osseo cerclage suture * Direct ligament suture * Internal brace * Ligament augmentation for primary repair * Suture anchors * Muscular reattachment * Other

    Time frame: Intraoperative

  14. Patient reported outcomes

    Pain Numeric Rating Scale (NRS). Local pain will be assessed with the Numerical Rating Scale (NRS). The scale range goes from 0 (no pain) to 10 (worst imaginable pain). A higher value correlates with greater pain.

    Time frame: Patients treated with clavicle plate: From baseline up to 24 months after surgery; Patients treated with clavicle hook plate: From baseline until device removal (approximately 3months) and up to 12 months after device removal

  15. Radiographical outcomes - Screw density and distribution

    Will be assessed in intraoperative or the first postoperative image by analyzing the screw placement with regards to the fracture line, their distribution and type of screws used

    Time frame: Patients treated with clavicle plate: Intraoperative, 2 weeks; Patients treated with clavicle hook plate: Intraoperative, 2 weeks

  16. Radiographical outcomes - Osteolysis

    Defined as the presence of a lucent line in the acromion around the tip and body hook of the clavicle hook plate. It will be documented as: * Not assessable * Partial: any lucency zone around the hook * Tip: lucency limited to the tip of the hook * Complete: lucency around all zones of the hook

    Time frame: Patients treated with clavicle hook plate: Intraoperative until device removal (approximately 3months)

  17. Radiographical outcomes - Bone union

    Bone union is defined as the presence of bridging callus in three of four cortices on orthogonal views

    Time frame: Patients treated with clavicle plate: From baseline up to 24 months after surgery; Patients treated with clavicle hook plate: From baseline until device removal (approximately 3months) and up to 12 months after device removal

  18. Radiographical outcomes - Quality of reduction

    In cases of fixation failure, quality of reduction will be assessed in the immediate postoperative radiographs and documented as: * Accurate reduction of simple fracture * Accurate alignment of complex fracture * Inaccurate reduction of simple fracture * Inaccurate alignment of complex fracture

    Time frame: Patients treated with clavicle plate: Immediately after surgery; Patients treated with clavicle hook plate: Immediately after surgery

  19. Radiographical outcomes - Acromioclavicular and coracoclavicular

    Acromioclavicular and coracoclavicular distances (in mm) will be assessed using AC joint anteroposterior and Alexander views (if available). The AC distance is the distance between the most medial point on the acromion visible on an anteroposterior view of the AC joint and a point on a line drawn perpendicular to the plane of the dorsal aspect of the lateral or fifth of the clavicle.

    Time frame: Patients treated with clavicle plate: From baseline up to 24 months after surgery; Patients treated with clavicle hook plate: From baseline until device removal (approximately 3months) and up to 12 months after device removal

07

Study locations

7 of 7 sites recruiting
08

References and documents

Publications

  • Jaeger M, Sussiek J, Beeres F, Carroll E, Conlan T, Cunningham D, Arnhold R, Lambert S. Observational case series on the clinical performance of the Variable Angle Clavicle Plate and Clavicle Hook Plate 2.7 systems: a study protocol. Front Surg. 2026 Jan 8;12:1694295. doi: 10.3389/fsurg.2025.1694295. eCollection 2025. PubMed 41583835 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04921865
Lead sponsor
AO Innovation Translation Center
Responsible party
Sponsor
First posted
Jun 10, 2021
Start date
Jul 10, 2024
Primary completion
Jan 31, 2027 (estimated)
Completion
Sep 30, 2029 (estimated)
Last update
Aug 29, 2025

Study contacts

Marco Minoia, PhD
Contact
marco.minoia@aofoundation.org
+41 79 612 09 67
Maria Clara Medina Giner
Contact
maria.medinaginer@aofoundation.org
+41 79 545 61 20
Simon Lambert
principal investigator · University College London Hospitals

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion